Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ANIK stock price vs AIR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AIR's multiple
Needs AIR P/S.
Implied fair value · at ANIK's multiple
Needs ANIK P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ANIK FY 2025 (ended Dec 31, 2025) · AIR FY 2026 (ended May 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Anika Therapeutics, Inc. · implied price per share
Bear
-$0.46
Base
-$0.55
Bull
-$0.63
AAR CORP. · implied price per share
Bear
$28.39
Base
$33.41
Bull
$38.42
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.07x
0.52x
Net debt / EBITDA
Leverage against operating earnings
30.49x
2.09x
Cash and equivalents
Liquid reserves on the balance sheet
$81.17M
$84.00M
Total debt
Interest-bearing obligations outstanding
$9.60M
$894.00M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ZIMMER BIOMET HOLDINGS, INC.
ANIK vs ZBH
STRYKER CORP
ANIK vs SYK
BECTON DICKINSON & CO
ANIK vs BDX
INTEGRA LIFESCIENCES HOLDINGS CORP
ANIK vs IART
TransDigm Group INC
ANIK vs TDG
Spirit AeroSystems Holdings, Inc.
ANIK vs SPR
Howmet Aerospace Inc.
ANIK vs HWM
HEXCEL CORP /DE/
ANIK vs HXL
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe ANIK can reaccelerate revenue growth and convert its 56.6% gross margin into sustained operating profitability, then hold or selectively add; otherwise, the current 2.5x P/S and -32.1% AIR-implied downside argue for caution because fundamentals are weaker than AIR's and leverage is elevated.
ANIK's current price of $21.42 is well above AIR-implied price of $14.53, implying -32.1% downside. The stock also sits above the top of AIR implied range and near the upper end of its historical band, suggesting the market is already pricing in a relatively rich valuation.
Supporting Metrics
